Literature DB >> 15279589

Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1.

David R Hout1, Ellyn R Mulcahy, Erik Pacyniak, Lisa M Gomez, Melissa L Gomez, Edward B Stephens.   

Abstract

The Vpu protein is the smallest of the proteins encoded by human immunodeficiency virus type 1 (HIV-1). This transmembrane protein interacts with the CD4 molecule in the rough endoplasmic reticulum (RER), resulting in its degradation via the proteasome pathway. Vpu also has been shown to enhance virion release from infected cells. While much has been learned about the function of Vpu in cell culture systems, its exact role in HIV-1 pathogenesis is still unknown. This has been primarily due to the lack of a suitable primate model system since vpu is found only in HIV-1 and simian immunodeficiency viruses isolated from chimpanzees (SIVcpz), and three species of old world monkeys within the genus Cercopithecus. Several laboratories have developed pathogenic molecular clones of simian-human immunodeficiency virus (SHIV) in which the tat, rev, vpu and env genes of HIV-1 are expressed in the genetic background of SIV. The availability of such clones has allowed investigators to assess the role of Vpu in pathogenesis using a relevant animal model. This review will focus on the current understanding of the structure-function relationships of Vpu protein and recent advances using the SHIV model to assess the role of Vpu in HIV-1 pathogenesis. Copyright 2004 Bentham Science Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279589     DOI: 10.2174/1570162043351246

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  17 in total

1.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

2.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.

Authors:  Beth Noble; Paolo Abada; Juan Nunez-Iglesias; Paula M Cannon
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.

Authors:  Gabriela Khoury; Gary Ewart; Carolyn Luscombe; Michelle Miller; John Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility.

Authors:  Tomoko Kobayashi; Hirotaka Ode; Takeshi Yoshida; Kei Sato; Peter Gee; Seiji P Yamamoto; Hirotaka Ebina; Klaus Strebel; Hironori Sato; Yoshio Koyanagi
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

6.  Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate.

Authors:  M Sarah Hill; Autumn Ruiz; Erik Pacyniak; David M Pinson; Nathan Culley; Bonnie Yen; Scott W Wong; Edward B Stephens
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

7.  Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.

Authors:  Ayse K Coskun; Marc van Maanen; Van Nguyen; Richard E Sutton
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expression.

Authors:  M Sarah Hill; Autumn Ruiz; Kimberly Schmitt; Edward B Stephens
Journal:  Virology       Date:  2009-11-27       Impact factor: 3.616

9.  Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

Authors:  Ivan Stratov; Amy Chung; Stephen J Kent
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Requirements of the membrane proximal tyrosine and dileucine-based sorting signals for efficient transport of the subtype C Vpu protein to the plasma membrane and in virus release.

Authors:  Autumn Ruiz; M Sarah Hill; Kimberly Schmitt; John Guatelli; Edward B Stephens
Journal:  Virology       Date:  2008-06-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.